COVID-19 Impact on Global Insomnia Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Insomnia Therapy Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Insomnia Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Non-pharmacological Therapy
  • 1.4.3 Pharmacological Therapy
• 1.5 Market by Application
  • 1.5.1 Global Insomnia Therapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Ambulatory Surgical Center
  • 1.5.4 Home Care
• 1.6 Coronavirus Disease 2019 (Covid-19): Insomnia Therapy Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Insomnia Therapy Industry
    • 1.6.1.1 Insomnia Therapy Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Insomnia Therapy Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Insomnia Therapy Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Insomnia Therapy Market Perspective (2015-2026)
• 2.2 Insomnia Therapy Growth Trends by Regions
  • 2.2.1 Insomnia Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Insomnia Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Insomnia Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Insomnia Therapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Insomnia Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Insomnia Therapy Players by Market Size
  • 3.1.1 Global Top Insomnia Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Insomnia Therapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Insomnia Therapy Market Concentration Ratio
  • 3.2.1 Global Insomnia Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Insomnia Therapy Revenue in 2019
• 3.3 Insomnia Therapy Key Players Head office and Area Served
• 3.4 Key Players Insomnia Therapy Product Solution and Service
• 3.5 Date of Enter into Insomnia Therapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Insomnia Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Insomnia Therapy Forecasted Market Size by Type (2021-2026)

5 Insomnia Therapy Breakdown Data by Application (2015-2026)

• 5.1 Global Insomnia Therapy Market Size by Application (2015-2020)
• 5.2 Global Insomnia Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Insomnia Therapy Market Size (2015-2020)
• 6.2 Insomnia Therapy Key Players in North America (2019-2020)
• 6.3 North America Insomnia Therapy Market Size by Type (2015-2020)
• 6.4 North America Insomnia Therapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Insomnia Therapy Market Size (2015-2020)
• 7.2 Insomnia Therapy Key Players in Europe (2019-2020)
• 7.3 Europe Insomnia Therapy Market Size by Type (2015-2020)
• 7.4 Europe Insomnia Therapy Market Size by Application (2015-2020)

8 China

• 8.1 China Insomnia Therapy Market Size (2015-2020)
• 8.2 Insomnia Therapy Key Players in China (2019-2020)
• 8.3 China Insomnia Therapy Market Size by Type (2015-2020)
• 8.4 China Insomnia Therapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Insomnia Therapy Market Size (2015-2020)
• 9.2 Insomnia Therapy Key Players in Japan (2019-2020)
• 9.3 Japan Insomnia Therapy Market Size by Type (2015-2020)
• 9.4 Japan Insomnia Therapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Insomnia Therapy Market Size (2015-2020)
• 10.2 Insomnia Therapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Insomnia Therapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Insomnia Therapy Market Size by Application (2015-2020)

11 India

• 11.1 India Insomnia Therapy Market Size (2015-2020)
• 11.2 Insomnia Therapy Key Players in India (2019-2020)
• 11.3 India Insomnia Therapy Market Size by Type (2015-2020)
• 11.4 India Insomnia Therapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Insomnia Therapy Market Size (2015-2020)
• 12.2 Insomnia Therapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Insomnia Therapy Market Size by Type (2015-2020)
• 12.4 Central & South America Insomnia Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Merck & Co.
  • 13.1.1 Merck & Co. Company Details
  • 13.1.2 Merck & Co. Business Overview and Its Total Revenue
  • 13.1.3 Merck & Co. Insomnia Therapy Introduction
  • 13.1.4 Merck & Co. Revenue in Insomnia Therapy Business (2015-2020))
  • 13.1.5 Merck & Co. Recent Development
• 13.2 Sanofi
  • 13.2.1 Sanofi Company Details
  • 13.2.2 Sanofi Business Overview and Its Total Revenue
  • 13.2.3 Sanofi Insomnia Therapy Introduction
  • 13.2.4 Sanofi Revenue in Insomnia Therapy Business (2015-2020)
  • 13.2.5 Sanofi Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview and Its Total Revenue
  • 13.3.3 Pfizer Insomnia Therapy Introduction
  • 13.3.4 Pfizer Revenue in Insomnia Therapy Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 Takeda Pharmaceutical Company Ltd.
  • 13.4.1 Takeda Pharmaceutical Company Ltd. Company Details
  • 13.4.2 Takeda Pharmaceutical Company Ltd. Business Overview and Its Total Revenue
  • 13.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Introduction
  • 13.4.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapy Business (2015-2020)
  • 13.4.5 Takeda Pharmaceutical Company Ltd. Recent Development
• 13.5 Purdue Pharmaceuticals L.P.
  • 13.5.1 Purdue Pharmaceuticals L.P. Company Details
  • 13.5.2 Purdue Pharmaceuticals L.P. Business Overview and Its Total Revenue
  • 13.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Introduction
  • 13.5.4 Purdue Pharmaceuticals L.P. Revenue in Insomnia Therapy Business (2015-2020)
  • 13.5.5 Purdue Pharmaceuticals L.P. Recent Development
• 13.6 Eisai, Co. Ltd.
  • 13.6.1 Eisai, Co. Ltd. Company Details
  • 13.6.2 Eisai, Co. Ltd. Business Overview and Its Total Revenue
  • 13.6.3 Eisai, Co. Ltd. Insomnia Therapy Introduction
  • 13.6.4 Eisai, Co. Ltd. Revenue in Insomnia Therapy Business (2015-2020)
  • 13.6.5 Eisai, Co. Ltd. Recent Development
• 13.7 Meda Consumer Healthcare
  • 13.7.1 Meda Consumer Healthcare Company Details
  • 13.7.2 Meda Consumer Healthcare Business Overview and Its Total Revenue
  • 13.7.3 Meda Consumer Healthcare Insomnia Therapy Introduction
  • 13.7.4 Meda Consumer Healthcare Revenue in Insomnia Therapy Business (2015-2020)
  • 13.7.5 Meda Consumer Healthcare Recent Development
• 13.8 Pernix Therapeutics
  • 13.8.1 Pernix Therapeutics Company Details
  • 13.8.2 Pernix Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Pernix Therapeutics Insomnia Therapy Introduction
  • 13.8.4 Pernix Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
  • 13.8.5 Pernix Therapeutics Recent Development
• 13.9 Vanda Pharmaceuticals
  • 13.9.1 Vanda Pharmaceuticals Company Details
  • 13.9.2 Vanda Pharmaceuticals Business Overview and Its Total Revenue
  • 13.9.3 Vanda Pharmaceuticals Insomnia Therapy Introduction
  • 13.9.4 Vanda Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
  • 13.9.5 Vanda Pharmaceuticals Recent Development
• 13.10 ECR Pharmaceuticals
  • 13.10.1 ECR Pharmaceuticals Company Details
  • 13.10.2 ECR Pharmaceuticals Business Overview and Its Total Revenue
  • 13.10.3 ECR Pharmaceuticals Insomnia Therapy Introduction
  • 13.10.4 ECR Pharmaceuticals Revenue in Insomnia Therapy Business (2015-2020)
  • 13.10.5 ECR Pharmaceuticals Recent Development
• 13.11 Fidia Farmaceutici
  • 10.11.1 Fidia Farmaceutici Company Details
  • 10.11.2 Fidia Farmaceutici Business Overview and Its Total Revenue
  • 10.11.3 Fidia Farmaceutici Insomnia Therapy Introduction
  • 10.11.4 Fidia Farmaceutici Revenue in Insomnia Therapy Business (2015-2020)
  • 10.11.5 Fidia Farmaceutici Recent Development
• 13.12 Dainippon Sumitomo
  • 10.12.1 Dainippon Sumitomo Company Details
  • 10.12.2 Dainippon Sumitomo Business Overview and Its Total Revenue
  • 10.12.3 Dainippon Sumitomo Insomnia Therapy Introduction
  • 10.12.4 Dainippon Sumitomo Revenue in Insomnia Therapy Business (2015-2020)
  • 10.12.5 Dainippon Sumitomo Recent Development
• 13.13 Biocodex
  • 10.13.1 Biocodex Company Details
  • 10.13.2 Biocodex Business Overview and Its Total Revenue
  • 10.13.3 Biocodex Insomnia Therapy Introduction
  • 10.13.4 Biocodex Revenue in Insomnia Therapy Business (2015-2020)
  • 10.13.5 Biocodex Recent Development
• 13.14 Eli Lilly and Company
  • 10.14.1 Eli Lilly and Company Company Details
  • 10.14.2 Eli Lilly and Company Business Overview and Its Total Revenue
  • 10.14.3 Eli Lilly and Company Insomnia Therapy Introduction
  • 10.14.4 Eli Lilly and Company Revenue in Insomnia Therapy Business (2015-2020)
  • 10.14.5 Eli Lilly and Company Recent Development
• 13.15 Ebb Therapeutics
  • 10.15.1 Ebb Therapeutics Company Details
  • 10.15.2 Ebb Therapeutics Business Overview and Its Total Revenue
  • 10.15.3 Ebb Therapeutics Insomnia Therapy Introduction
  • 10.15.4 Ebb Therapeutics Revenue in Insomnia Therapy Business (2015-2020)
  • 10.15.5 Ebb Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer